Mondottica’s new Christian Lacroix collection features quilted-texture leather inserts in metal or exclusive Mazzuchelli laminated acetates. The season’s iconic prints are transferred onto acetate and covered in rich colours. Models: CL3040, CL1048, CL1051 and CL1052. Distributed by Centennial Optical. www.centennialoptical.com
University of Waterloo develops new treatment for dry eyes
Scientists from the University of Waterloo have developed a nanoparticle-based topical solution to combat dry eyes with a single weekly application.
Patients currently have to administer a solution three times a day to reduce pain and irritation. The solution developed at the University of Waterloo gradually delivers the correct amount of drug-infused nanoparticules to the surface of the eyeball over a period of five days before the body metabolizes them.
One weekly dose replaces 15 doses or more of the traditional treatments. The substance causes no irritation. If clinical trials are conclusive, this therapy could be available on the market within five years.
For further information: http://link.springer.com/article/10.1007/s12274-014-0547-3#page-1
ROLF Spectacles launches evolved collection
The new evolved collection from ROLF Spectacles includes 17 new models, five of which are wood and four stone. The Foursome 102 style is reminiscent of classic English cars from the 1950s. The smoked eucalyptus frame is radiant with its shiny surface and wavy texture. http://www.rolf-spectacles.com/
Sales growth at Sàfilo
The North American market is the driving force behind Sàfilo’s third quarter growth.
Sàfilo Group reported an increase in sales of 7.3% in the third quarter of 2014, compared with the same period in 2013. The company’s total revenues reached CA$371.2 million during the quarter.
In the North American market, sales increased by 14.1% over the same quarter in 2013. Sales in emerging markets, a priority for Sàfilo, increased by 27%, thanks to the strong performance of the Chinese and Brazilian markets.
Sales increased by 1.9% in Europe but dropped by 3.7% in Asia.
For further information: http://investors-en.safilo.com/phoenix.zhtml?c=195673&p=irol-newsArticle_pf&ID=1986112
Record quarter for Allergan
In the third quarter of 2014, Allergan posted its strongest sales increase in the company’s history.
Allergan’s sales were CA$2 billion in the third quarter, up by 17.2% compared with the same period in 2013. Earnings totalled CA$350 million.
Pharmaceutical eyecare products (including Refresh and Restasis) showed a 14.2% sales increase to CA$915 million.
Allergan could not miss out on trumpeting its success, and perhaps it was thumbing its nose at Valeant. The latter is attempting to acquire Allergan and recently boasted its… second best quarter ever (see news clip from October 30).
For more information: http://agn.client.shareholder.com/releasedetail.cfm?ReleaseID=878172
